BioSpace News Archive

Business

RenovoRx Reports Second Quarter 2022 Financial Results

RenovoRx, Inc. today reported its financial results for the quarter ended June 30, 2022.

August 15, 2022
·
8 min read
Deals

Black Bird Biotech Management Affirms Long-Term Commitment, Exchanges One-Third, over 120 Million, of Outstanding Common Shares for Preferred Shares

Black Bird Biotech, Inc. announced that the members of its Board of Directors have agreed to exchange a total of nearly 124 million shares, or approximately 36%, of the Company’s outstanding common stock for shares of a new Series A Preferred Stock.

August 15, 2022
·
4 min read
Biotech Beach

Lineage to Present at H.C. Wainwright & Co. 2nd Annual Virtual Ophthalmology Conference

Lineage to Present at H.C. Wainwright & Co. 2nd Annual Virtual Ophthalmology Conference.

August 15, 2022
·
2 min read
Business

Petros Pharmaceuticals Reports Record Revenue and Gross Profit During Second Quarter 2022

Petros Pharmaceuticals, Inc. today announced financial results for the second quarter ended June 30, 2022.

August 15, 2022
·
20 min read
Business

Vaccinex Reports Second Quarter 2022 Results and Provides Corporate Update; Excellent Progress in Pepinemab Clinical Programs

Vaccinex, Inc. today announced financial results for the second quarter ended June 30, 2022 and provided a corporate update on key events since April, 2022 (the last 5 months).

August 15, 2022
·
12 min read
Business

Guardant Health Expands Use of Guardant Reveal™ Liquid Biopsy Test for Residual Disease Detection and Recurrence Monitoring to Include Early-Stage Breast and Lung Cancers

Guardant Health Inc. announced today that Guardant Reveal™, the only tissue-free test for the detection of residual and recurrent disease for colorectal cancer (CRC), is now available for patients with breast and lung cancers.

August 15, 2022
·
3 min read
Business

Anixa Biosciences Announces Treatment of First Patient in its Ovarian Cancer CAR-T Clinical Trial

Anixa Biosciences, Inc. today announced that, in conjunction with its partner Moffitt Cancer Center, it has commenced treatment of the first patient in the clinical trial of its novel chimeric antigen receptor T-cell (CAR-T) therapy for ovarian cancer.

August 15, 2022
·
5 min read
Deals

Probo Medical Acquires Mi Healthcare

Probo Medical (“Probo”), a leading global provider of medical imaging equipment, parts, repair, and service, announced the acquisition of Mi Healthcare.

August 15, 2022
·
2 min read
Business

CV Sciences, Inc. Reports Second Quarter 2022 Financial Results

CV Sciences, Inc. (OTCQB: CVSI) (the “Company”, “CV Sciences”, “our”, “us” or “we”), a preeminent consumer wellness company specializing in hemp extracts and other proven science-backed, natural ingredients and products, today announced its financial results for the quarter ended June 30, 2022.

August 15, 2022
·
13 min read
Business

Virpax Pharmaceuticals Reports 2022 Second Quarter Results and Recent Developments

Virpax Pharmaceuticals Reports 2022 Second Quarter Results and Recent Developments.

August 15, 2022
·
13 min read